FPA March 2022 Central

0
https://issuu.com/communityadvocate/docs/fpa_march_22_central_web  
Aduhelm is the medication recently approved by the Food and Drug Administration as a treatment for early-stage Alzheimer’s disease. Photo courtesy of Biogen

Medicare To Limit Coverage Of New Alzheimer’s Drug

0
By Brett Peruzzi, Managing Editor Region - Aduhelm, the Alzheimer's disease treatment approved last summer by the Food and Drug Administration (FDA), has run into...